Amit Rakhit, MD
banner
amitrakhit.bsky.social
Amit Rakhit, MD
@amitrakhit.bsky.social
10 followers 1 following 48 posts
I'm the Chief Medical Officer at BlueRock Therapeutics and an experienced biotech executive focusing on stem cell therapies hoping to develop medicines that may one day transform medical practice across multiple therapeutic areas.
Posts Media Videos Starter Packs
In biotech, where precision meets uncertainty, “rounded-corner” leaders blend rigor with empathy. They balance data and compassion, fostering trust and curiosity. By valuing people as much as performance, they drive innovation grounded in humanity, which is key to lasting scientific progress.
Why I Love Working With Leaders Who Have 'Rounded Corners'
Life science leaders with rounded corners lead to more enduring progress than razor-sharp perfection ever could, writes Tara Miller, founding partner at Artemis Factor.
www.lifescienceleader.com
The survey highlights a striking resilience: trans & nonbinary immigrants face higher poverty and barriers yet report better mental health and civic engagement than non-immigrants. When communities are supported and services reflect cultural understanding, strength and agency naturally follow.
A survey on trans & nonbinary immigrants provides surprising insight into their mental health - LGBTQ Nation
The data on political engagement and willingness to contact police also surprised researchers.
www.lgbtqnation.com
AI can accelerate research, but impact comes when executives proactively adopt emerging technologies, validate them rigorously, and align them with clinical realities. #BiotechLeaders who embrace regular change and approach innovation thoughtfully will be the ones turning potential into therapies.
Between hype and hope: Seattle biotech leaders size up AI’s real impact on drug development
Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality.
www.geekwire.com
#Parkinson’s motor symptoms are linked to alpha-synuclein, but cognitive decline appears driven by GBA mutations disrupting synaptic communication. This study highlights distinct mechanisms behind symptoms and opens new avenues to understand and treat dementia in Parkinson’s patients.
How Gene Mutations Drive Dementia in Parkinson’s Disease
New findings reveal motor and cognitive deficits arise through separate mechanisms in Parkinson’s disease, challenging previous thinking.
medicine.yale.edu
Huntington’s gene therapy, slowing the disease by 75% is a historic achievement, turning decades of despair into hope. Precision medicine and bravery are changing lives, showing that science can rewrite the future. Access and cost remain hurdles, but the promise is real and profound.
Huntington's disease successfully treated for first time
One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful doctors tell BBC.
www.bbc.com
Leaving the ICU for the C-suite taught me that impact goes beyond the bedside. Clinicians bring empathy, critical thinking, and teamwork that scale globally. Be curious, know your goals, and build networks. Medicine is the foundation; industry is a bigger stage to help patients.
Dr. Amit Rakhit: How to Transition From Physician to Industry Leader | C-Suite Brief
Families came from around the globe, seeking hope and answers at one of the few institutions capable of treating the most complex pediatric heart conditions.
www.csuitebrief.com
The stories of June, David, and Wendy remind us how urgent #Alzheimer’s research is. As high-risk APOE4-4 carriers, they’ve taken action to protect their brains, advocate for research, and support others. Lifestyle, innovation, and awareness all matter.
These scientists found Alzheimer's in their genes. Here's what they did next
Three scientists learned they carry genes that dramatically increase their risk for Alzheimer's disease. Now they're working to keep their brains healthy.
www.npr.org
Happy #ReadAnEbookDay! 📚 There’s nothing like diving into a story or learning something new from the comfort of your favorite reading spot.
One of the most exciting developments is the rise of #CellTherapies for #neurodegenerative diseases. What excites me most is the collaboration needed between regulators, scientists, and biopharma to bring these innovations safely to patients. Getting this right could transform neurological care.
#BiotechLeadership asks us to lead people through constant change. I like to lead this charge with #gratitude. Appreciating contributions and being present with teams unlocks trust, creativity, and #resilience. In high-uncertainty environments, gratitude is deeply transformative.
#Biotech is global, but #regulation isn’t. Success demands strategic #localization and adapting to each region’s priorities while keeping patients at the center. Embedding regulatory strategy early accelerates access. Patients are waiting, and we must act. Thank you, MSN and Charente Carr!
MSN
www.msn.com
#Acupuncture shows promise as an adjunct #therapy for post-stroke #dysphagia, improving swallowing function when combined with rehab. However, most existing studies have low-quality evidence and reporting gaps. More rigorous research is crucial to confirm its benefits and guide clinical use.
Frontiers | The efficacy of acupuncture for post-stroke dysphagia: an overview of systematic reviews and meta-analyses
Background: Acupuncture has been widely used in clinical rehabilitation as an adjunctive therapy for post-stroke dysphagia (PSD).Although numerous meta-analy...
www.frontiersin.org
Hey everyone! I’m excited to announce that my website is now live. It’s a great place where I’ll be sharing news, events, and updates with you all. I truly appreciate your support and can’t wait to connect more here! #Biotech
Amit Rakhit | The Official Website of Amit Rakhit
Amit Rakhit Is a Biotech Executive, Chief Medical Officer at BlueRock Therapeutics, Former CEO of Flare Therapeutics & Sporos Bioventures...
www.amitrakhit.com
Ending #LGBTQ+ #HealthResearch doesn’t just harm one group -- it sets all of science back. When we exclude millions from studies, we compromise care, overlook critical insights, and let bias shape medicine. #HealthEquity requires inclusion, not erasure.
Contributor: Ending LGBTQ+ health research will leave science in the dark
We’ve seen the consequences of neglecting disparities before. For decades, medical problems unique to Black Americans were understudied and unsolved.
www.latimes.com
#BiotechLeadership has evolved. Scientific rigor, while vital, requires more- it’s about leading through #change, balancing business with #empathy, and staying mission-focused. Today’s #leaders adapt quickly, inspire teams, and communicate clearly.
#RainbowSeniorsROC proves advocacy has no age limit. From Pride picnics to protests, they're building bridges between generations and standing strong for #LGBTQ rights, safety, and inclusion. Their decades of activism laid the groundwork for progress.
State of Pride: 'We need to do everything we can for the younger generation of LGBTQ kids'
Rainbow Seniors ROC is an advocacy, service and social group for Rochester-area LGBTQ adults who are 50 or older.
www.democratandchronicle.com
Strong #leadership is essential in #biotech. In a space driven by complex science and high stakes for #patients, visionary leaders align teams, inspire trust, and turn bold ideas into real therapies. Without them, even the best #innovations risk falling short.
#DigitalTwins and #VirtualTrials are transforming rare disease research -- enabling faster, safer, and more #inclusive drug development. By simulating patient responses, researchers can overcome small population barriers and accelerate access to life-changing therapies.
Digital twins and virtual trials: A new era in rare disease drug development
With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers can now transform their strategies by using models to duplicate biological systems.
pharmaphorum.com
#Representation saves lives, and Kikis with Louie is doing just that. This powerful new series creates a safe, affirming space where LGBTQ youth of color can see themselves, hear real talk on identity, life-saving health ed, and mental health -- and know they’re not alone. #LGBTQYouth
New YouTube Series, Kikis With Louie, Explores Social and Cultural Issues Impacting LGBTQ Youth of Color - Advocates for Youth
In response to staggering rates of LGBTQ bullying and suicide ideation, Advocates for Youth’s new series creates a safe and affirming space where LGBTQ
www.advocatesforyouth.org
Boosting #p53 to fight cancer may unintentionally weaken brain and eye barriers, new research finds. #MDM2 inhibitors could disrupt #vascular integrity, raising risks of #neuroinflammation. #NCAPH also emerges as a key gene in retinal disease. #CancerResearch
Cancer Pathway Found to Weaken Brain and Eye Barriers - Neuroscience News
Researchers have uncovered a surprising connection between a cancer-related signaling pathway and the blood-brain and blood-retina barriers.
neurosciencenews.com
New #NorthwesternMedicine research suggests a usually harmless virus, #HPgV, may play a role in #Parkinson’s disease. Found in the brains and spinal fluid of Parkinson’s patients but not others, it could interact with genetics to influence disease development. Study ongoing. #ParkinsonsResearch
Researchers discover a possible environmental trigger to Parkinson’s disease
New research from Northwestern Medicine detects a common, but usually harmless virus in the brains of Parkinson’s patients
news.nm.org
#Leadership in #biotech demands more than #innovation. It requires vision, adaptability, and ethical clarity. Navigating complex science, regulation, and impact on human lives means leading with both head and heart. The best biotech leaders inspire trust and push boundaries responsibly.
#AI, #MachineLearning, and real-world #data are transforming #RareDisease research by uncovering patterns, speeding diagnosis, and improving patient tracking. Breaking data silos and ensuring quality, interoperable data helps accelerate trials and treatments.
Data Technology + RWD Are Positive for Rare Disease Treatment - MedCity News
Technology that offers tools that conform, de-identify, link and aggregate data and data science tools like AI, machine learning and advanced analytics, can help those researching rare diseases overcome the hurdles they face in discovery and development. 
medcitynews.com